Host: |
Mouse |
Applications: |
WB/ELISA |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Mouse monoclonal antibody anti-CD27 antigen (160-260) is suitable for use in Western Blot and ELISA research applications. |
Clonality: |
Monoclonal |
Clone ID: |
PT1818 |
Conjugation: |
Unconjugated |
Isotype: |
IgG2bk |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
CD27 |
Gene ID: |
939 |
Uniprot ID: |
CD27_HUMAN |
Immunogen Region: |
160-260 |
Specificity: |
This antibody detects endogenous levels of CD27 at Human, Predict react with Mouse |
Immunogen: |
Synthesized peptide derived from human CD27 AA range: 160-260 |
Tissue Specificity | Found in most T-lymphocytes. |
Post Translational Modifications | Phosphorylated. O-glycosylated with core 1 or possibly core 8 glycans. |
Function | Receptor for CD70/CD27L. May play a role in survival of activated T-cells. May play a role in apoptosis through association with SIVA1. |
Protein Name | Cd27 AntigenCd27l ReceptorT-Cell Activation Antigen Cd27T14Tumor Necrosis Factor Receptor Superfamily Member 7Cd Antigen Cd27 |
Database Links | Reactome: R-HSA-5669034 |
Cellular Localisation | MembraneSingle-Pass Type I Membrane Protein |
Alternative Antibody Names | Anti-Cd27 Antigen antibodyAnti-Cd27l Receptor antibodyAnti-T-Cell Activation Antigen Cd27 antibodyAnti-T14 antibodyAnti-Tumor Necrosis Factor Receptor Superfamily Member 7 antibodyAnti-Cd Antigen Cd27 antibodyAnti-CD27 antibodyAnti-TNFRSF7 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance